Depletion of MRPL35 inhibits gastric carcinoma cell proliferation by regulating downstream signaling proteins

Figure 1 MRPL35 is highly up-regulated in gastric carcinoma. A-C: The expression of MRPL35 in stomach adenocarcinoma based on sample type (A), tumor grade (B), and individual cancer stage (C). The results were based on data from the public database UALCAN (www.ualcan.path.uab.edu); D: Kaplan-Meier overall survival chart. The results were based on data from the public database KMplot (www.kmplot.com); E-G: Overall survival of patients with high and low expression of MRPL35 in different pathological grades of gastric carcinoma (GC) (E, moderate; F, poor; G, well); H-K: Overall survival of patients with high and low expression of MRPL35 in different pathological stages of GC (H, stage I; I, stage II; J, stage III; K, stage IV). The results were based on data from the public database KMplot (www.kmplot.com). ^aP < 0.05, ^bP < 0.01, ^cP < 0.001. STAD: Stomach adenocarcinoma; HR: Hazard ratio.